Gülden Anataca
Clinical trials sponsored by Gülden Anataca, explained in plain language.
-
Could a pancreatic peptide hold clues to PCOS-Related insulin resistance?
Knowledge-focused Not yet recruitingThis study looks at whether a hormone called preptin, which is released alongside insulin, is linked to insulin resistance in women with polycystic ovary syndrome (PCOS). Researchers will measure preptin levels in 60 women diagnosed with PCOS and compare them to markers of insuli…
Sponsor: GÜLDEN ANATACA • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
A muscle protein may signal nerve damage in diabetes — study puts it to the test
Knowledge-focused Not yet recruitingThis study investigates whether blood levels of irisin, a protein linked to glucose metabolism and nerve protection, differ in people with type 2 diabetes who have diabetic polyneuropathy (nerve damage) compared to those without it and healthy controls. Researchers will measure i…
Sponsor: GÜLDEN ANATACA • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
A blood marker may reveal how well diabetes treatments are working
Knowledge-focused Not yet recruitingThis study looks at whether levels of a protein called Neuregulin-4 (NRG4) in the blood are linked to obesity, insulin resistance, and different diabetes treatments in people with type 2 diabetes. Researchers will compare NRG4 levels across groups including obese and non-obese pa…
Sponsor: GÜLDEN ANATACA • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC